John Sweetenham, MD, associate director for clinical affairs, Harold G. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, discusses unanswered questions with CAR T-cell therapy in pediatric acute lymphoblastic leukemia.
John Sweetenham, MD
Advertisement
Articles by John Sweetenham, MD
Advertisement
Latest Updated Articles
Dr. Sweetenham on Unanswered Questions With CAR T-Cell Therapy in Pediatric ALLPublished: June 1st 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
2
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
3
Key Unknowns Remain in Cell and Gene Therapy
4
CGTLive®’s Weekly Rewind – December 5, 2025
5
